Perspective Therapeutics (CATX) Return on Capital Employed Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -81.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 252.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 23.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 141.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -110.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 49.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 658.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -231.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 200.00
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -813.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -813.00
Dec 31, 2025 -1,890.00
Sep 30, 2025 -2,610.00
Jun 30, 2025 -2,051.00
Mar 31, 2025 -546.00
Dec 31, 2024 2,012.00
Sep 30, 2024 1,656.00
Jun 30, 2024 1,030.00
Mar 31, 2024 -13.00
Dec 31, 2023 -2,297.00
Sep 30, 2023 -1,686.00
Jun 30, 2023 -1,372.00
Mar 31, 2023 -1,924.00
Dec 31, 2022 -1,824.00
Sep 30, 2022 -1,189.00
Jun 30, 2022 -1,027.00
Mar 31, 2022 245.00
Dec 31, 2021 2,682.00
Sep 30, 2021 4,525.00
Jun 30, 2021 4,645.00
Mar 31, 2021 3,909.00
Dec 31, 2020 1,755.00
Sep 30, 2020 736.00
Jun 30, 2020 1,126.00
Mar 31, 2020 1,789.00
Dec 31, 2019 1,117.00
Sep 30, 2019 2,001.00
Jun 30, 2019 5,199.00
Mar 31, 2019 1,502.00
Dec 31, 2018 799.00
Sep 30, 2018 -1,632.00
Jun 30, 2018 -5,860.00
Mar 31, 2018 -3,778.00
Dec 31, 2017 -3,091.00
Sep 30, 2017 -2,588.00
Jun 30, 2017 -2,410.00
Mar 31, 2017 -1,688.00
Jun 30, 2014 4,305.00
Mar 31, 2014 2,637.00
Dec 31, 2013 -588.00
Sep 30, 2013 -1,263.00
Jun 30, 2013 -874.00
Mar 31, 2013 -578.00
Dec 31, 2012 187.00
Sep 30, 2012 371.00